VIAD PHARMA ApS: Financial statements 2025
CVR: 36433892
VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. That is a decrease of 44.1% compared with the year before. Equity amounted to DKK 236,399. The solvency ratio was 11.4%. The company had 1 employee in the financial year.
- Gross Profit
- 1,031,002 kr.
- Profit/Loss
- 168,032 kr.
- Equity
- 236,399 kr.
- Total Assets
- 2,068,658 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1 mio. | 168 t. | 236 t. | 1 |
| 2024 | - | 1.8 mio. | 809 t. | 877 t. | - |
| 2023 | - | 1.3 mio. | 376 t. | 445 t. | - |
| 2022 | - | 1 mio. | 188 t. | 257 t. | - |
| 2021 | - | 1 mio. | 250 t. | 319 t. | - |
Find more companies like VIAD PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
VIAD PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 1,843,899, and the net result was DKK 808,813.
About VIAD PHARMA ApS
VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity amounted to DKK 236,399.
